Together, these results suggest that Raf‐1 signals through p70S6K to exert its pivotal role in NSCLC tumorigenicity, further confirming that p70S6K is a bona fide downstream target of Raf‐1. The gene discussed is RPS6KB1; the disease is non-small cell lung carcinoma.